INmune Bio, Inc. (INMB)
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
$102.56M
Dr. Raymond Joseph Tesi M.D.
10.00
Boca Raton, FL
Feb 04, 2019
-2.53
$-2.05
2.06
2.36
-44,402.35%
-2.84
-0.27
2.89
1,291.67
2.36
-71.95%
-101.34%
Similar stocks (14)
Cassava Sciences, Inc.
SAVA
Eliem Therapeutics, Inc.
ELYM
Anavex Life Sciences Corp.
AVXL
TScan Therapeutics, Inc.
TCRX
Anixa Biosciences, Inc.
ANIX
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
Cognition Therapeutics, Inc.
CGTX
BioVie Inc.
BIVI
IN8bio, Inc.
INAB
TFF Pharmaceuticals, Inc.
TFFP
Dermata Therapeutics, Inc.
DRMA
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.01941%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00571%
iShares Russell 2000 ETF
IWM
0.00283%
ProShares Ultra Russell2000
UWM
0.0010845402442609682%
ProShares UltraPro Russell2000
URTY
5.339167451836245e-4%
ProShares Hedge Replication ETF
HDG
4.523802958653303e-4%
Dimensional US Sustainability Core 1 ETF
DFSU
4.34e-6%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
Cassava Sciences, Inc.
SAVA
Eliem Therapeutics, Inc.
ELYM
Anavex Life Sciences Corp.
AVXL
TScan Therapeutics, Inc.
TCRX
Anixa Biosciences, Inc.
ANIX
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
Cognition Therapeutics, Inc.
CGTX
BioVie Inc.
BIVI
IN8bio, Inc.
INAB
TFF Pharmaceuticals, Inc.
TFFP
Dermata Therapeutics, Inc.
DRMA
ETF Exposure (21)
iShares Micro-Cap ETF
IWC
0.01941%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00571%
iShares Russell 2000 ETF
IWM
0.00283%
ProShares Ultra Russell2000
UWM
0.0010845402442609682%
ProShares UltraPro Russell2000
URTY
5.339167451836245e-4%
ProShares Hedge Replication ETF
HDG
4.523802958653303e-4%
Dimensional US Sustainability Core 1 ETF
DFSU
4.34e-6%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%